Lysine methyltransferase SMYD2 promotes triple negative breast cancer progression

Xiaoyan Li(University of Kansas Medical Center), Xiaogang Li(Mayo Clinic)
Cell Death and Disease
February 27, 2018
Cited by 104


Related Papers